Jin Rong Jie·2025-09-01 04:09Market Overview - A-shares opened higher on September 1, with the Shanghai Composite Index up 0.12% to 3862.65 points, the Shenzhen Component Index up 0.11% to 12710.24 points, and the ChiNext Index up 0.55% to 2906.03 points, while the STAR Market 50 Index rose 0.71% to 1350.77 points [1] - The total trading volume in the Shanghai and Shenzhen markets reached 1.83 trillion yuan, with over 3100 stocks rising [1] Sector Performance Gold Sector - The gold and precious metals sector saw significant gains, with stocks like Western Gold and others hitting the daily limit [2] - Spot silver prices surpassed $40 per ounce for the first time since 2011, with several international financial institutions bullish on gold prices, including UBS raising its 2026 gold price target to $3700 per ounce and Bank of America predicting a peak of $4000 per ounce by mid-2026 [2] Innovative Drug Sector - The innovative drug sector rebounded strongly, with companies like Maiwei Biotech and BeiGene reaching historical highs, and stocks such as Changchun High-tech and others hitting the daily limit [3] - The National Healthcare Security Administration recently published a preliminary list of drugs for the 2025 medical insurance and commercial insurance innovation drug directory, featuring new drugs including CAR-T products and several "first and only" global products [3] Chip Sector - The chip sector experienced a brief surge before retreating, with stocks like Liyang Chip hitting the daily limit and others like Tai Lingwei and Huahong Technology also rising [4] - Positive news included Alibaba's AI product revenue achieving triple-digit growth for eight consecutive quarters and Goldman Sachs raising the target price for Cambricon to 2104 yuan, benefiting from the expansion of cloud spending in China [4]